Clinical Trials Browser

Terminated × Leiomyosarcoma × avelumab × Clear all

NCT03074318 2022-04-29

Avelumab and Trabectedin in Treating Patients With Liposarcoma or Leiomyosarcoma That is Metastatic or Cannot Be Removed by Surgery

Phase 1/2 Terminated

35 enrolled 21 charts

Leiomyosarcoma, Liposarcoma